Border to Coast Pensions Partnership Ltd lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 28.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 181,552 shares of the healthcare conglomerate's stock after buying an additional 39,913 shares during the period. Border to Coast Pensions Partnership Ltd's holdings in UnitedHealth Group were worth $56,639,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Bayforest Capital Ltd boosted its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Copia Wealth Management purchased a new position in UnitedHealth Group in the fourth quarter worth $42,000. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at $42,000. Finally, O Brien Wealth Partners LLC grew its holdings in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares during the period. Institutional investors own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
UNH has been the topic of several research reports. Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Robert W. Baird restated an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Finally, JPMorgan Chase & Co. dropped their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $358.95.
Read Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
UNH stock traded up $4.80 on Monday, hitting $341.49. The company had a trading volume of 8,883,715 shares, compared to its average volume of 13,010,308. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock has a market cap of $309.27 billion, a price-to-earnings ratio of 14.80, a P/E/G ratio of 2.20 and a beta of 0.44. The stock's 50-day simple moving average is $295.67 and its 200 day simple moving average is $363.56.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.